Complexity in Health, Education, and Social Support for Children and Young People With Life-limiting Conditions. (CHESS)

November 13, 2025 updated by: King's College London

CHESS - Complexity and Outcomes in Health, Education, and Social Support Among Children and Young People With Life-limiting Conditions: Establishing a Multisectoral Collaboration and Conceptual Framework to Advance Evidence and Practice.

Children and young people (CYP) with life-limiting conditions represent a growing population with complex care needs that span health, education, and social care systems. These children often have multiple diagnoses, rely on medical technologies, and experience prolonged trajectories of illness. Despite this, care remains fragmented, services are poorly integrated, and definitions of "complexity" are variable, inconsistent, and inadequately reflect the lived experience of families and the perspectives of professionals.

The CHESS (Complexity in Health, Education, and Social Support) study aims to develop a shared, evidence-informed understanding of "complexity" in the context of CYP with life-limiting conditions. The study will be delivered by a multi-disciplinary, multisectoral research team and is funded by a National Institute for Health and Care Research (NIHR) Programme Development Grant. This research will provide the foundational work to inform the design and implementation of a future NIHR Programme Grant focused on the development and testing of a child-centred, nationally applicable case mix classification system to support integrated multisector care and resource allocation.

This qualitative study involves two stages. Stage 1 consists of semi-structured interviews with (i) CYP aged 5-17 years with a life-limiting condition, (ii) parents/carers (including bereaved parents and parents of children aged under 5 years), and (iii) professionals across healthcare, social care, and education sectors. These interviews aim to elicit stakeholder understandings of "complexity," how it is experienced and enacted in care, and the implications for service access, coordination, and outcomes.

Stage 2 comprises a series of stakeholder workshops to review, refine, and synthesise findings from Stage 1 and a parallel realist review. Using consensus methods including the Nominal Group Technique, the workshops will co-develop a cross-sectoral conceptual definition of "complexity" and produce a logic model to guide integrated care delivery for this population.

The CHESS study seeks to address a critical evidence gap in how complexity is understood, measured, and supported across systems. By incorporating the voices of children, families, and professionals across sectors, this study will generate new conceptual clarity, build a foundation for improved outcomes, and contribute directly to the national agenda on equity, quality, and integration in paediatric palliative and complex care.

Study Overview

Status

Not yet recruiting

Conditions

Intervention / Treatment

Detailed Description

  1. Background and Rationale

    Children and young people living with life-limiting conditions (LLCs) represent a population with profoundly complex and multidimensional needs. These conditions, which include both life-limiting and life-threatening diagnoses, are characterised by an absence of curative options and, in many cases, uncertain illness trajectories. Advances in medical care mean that children often survive longer than previously expected, but with increasing medical, social, and educational complexity.

    Care for this group typically spans multiple sectors: highly specialised medical teams, allied health professionals, children's hospices, social services, and educational systems. Parents frequently report fragmented services, difficulties in navigating between health, education, and social care, and inequitable access to essential resources such as medical technologies, equipment, and tailored educational support. Despite being a relatively small population, these children account for disproportionately high resource utilisation, including frequent and prolonged hospital admissions, intensive care stays, and substantial reliance on community-based services.

    The absence of a shared definition of "complexity" across health, education, and social care settings poses a major barrier to effective care delivery. Services lack a consistent framework for recognising, measuring, and responding to complexity, resulting in inequitable distribution of resources and difficulties in evaluating outcomes. Research into children with neurodisability has attempted to capture aspects of complexity, but such tools are impractical in routine settings and insufficiently inclusive of the breadth of needs among children with LLCs.

    Previous initiatives have shown progress in developing outcome measures in paediatric palliative care and in mapping models of end-of-life care. However, no work has systematically brought together children, families, professionals, and policy stakeholders across sectors to build a conceptual model of complexity. In contrast, adult palliative care in the UK has successfully developed and implemented classification frameworks that inform both care and policy. A similar evidence base is urgently needed for children.

    The CHESS study (Complexity in Health, Education, and Social Support) addresses this evidence gap. By drawing on interviews with children, parents, and professionals, and by convening cross-sector workshops, this study will generate a consensus definition of complexity and a logic model of integrated multisector care. This framework will inform the development of a child-centred, nationally applicable classification system for future research and service planning.

  2. Study Purpose and Objectives

    The overarching purpose of CHESS is to build an evidence-based conceptual model of complexity in children with LLCs that is recognised across health, education, and social care sectors. This study is funded by the UK National Institute for Health and Care Research (NIHR) through a Programme Development Grant, and its outputs will underpin a future Programme Grant to design and test a case-mix classification for integrated care.

    Primary Objective

    To develop a cross-sector, evidence-based conceptual model of complexity for children with LLCs, derived from qualitative interviews and stakeholder workshops.

    Stage 1: Interviews

    To capture the perspectives of children, parents (including bereaved parents), and professionals on the meaning and operationalisation of "complexity."

    To understand children's experiences of their care needs, the supports they value, and barriers to meeting these needs.

    To identify parents' views on gaps in provision and how complexity influences the challenges they face.

    To explore professionals' definitions of complexity and their approaches to care planning.

    Stage 2: Workshops

    To build consensus on how complexity is defined and operationalised across sectors.

    To identify key components, processes, and outcomes essential for delivering integrated care.

    To develop a logic model of integrated care, with agreed indicators and outputs that reflect complexity.

    Secondary Objectives

    To establish a collaborative research partnership across multiple disciplines and sectors.

    To generate findings that support equitable resource allocation and guide future policy.

    To strengthen patient and public involvement (PPI) in conceptualising and shaping research on complexity.

  3. Study Design and Methodology

    This is a qualitative, multi-stage study consisting of two sequential components:

    Stage 1 - Semi-structured Interviews

    Participants: children (aged 5-17 years), parents/carers (including bereaved parents and parents of children aged under 5), and professionals (health, social care, education).

    Purpose: to capture diverse views on complexity, using purposive sampling to ensure variation in age, condition, ethnicity, socio-economic status, and professional background.

    Method: in-depth, semi-structured interviews, supported by age-appropriate tools (e.g., Talking Mats™, draw/play methods).

    Stage 2 - Stakeholder Workshops

    Three initial workshops (~30 participants each) involving parents, professionals, researchers, and carers.

    A final consensus workshop (~30 participants) using Nominal Group Technique to refine definitions and logic models.

    Data: transcripts and facilitated discussions analysed to develop a consensus definition and a framework for integrated care.

    The design is informed by a pragmatist research paradigm, acknowledging the experiential and contextual nature of complexity. Appreciative Inquiry principles will guide workshops, focusing on "what works" in integrated care.

    Study Duration: 9 months 31 days.

  4. Participants: Eligibility and Recruitment 4.1 Children and Young People

    Inclusion

    Aged 5-17 years.

    Diagnosed with a life-limiting condition (as defined by Together for Short Lives).

    Able to communicate verbally, through play/drawing, Talking Mats™, or via a parent proxy.

    Exclusion

    Unable to communicate using available methods.

    Non-English speakers where NHS translation services are unavailable.

    Considered by clinical staff at participating centres to be at risk of undue distress.

    Recruitment

    Through NHS trusts, hospices, and community organisations serving children with LLCs.

    Care teams identify eligible children and seek parental consent for contact.

    4.2 Parents and Carers

    Inclusion

    Parents/carers of children aged 0-17 years with an LLC.

    Bereaved parents (>3 months since bereavement).

    Exclusion

    Recently bereaved (<3 months).

    Unable to provide informed consent.

    At risk of psychological harm if participating.

    4.3 Professionals

    Inclusion

    Healthcare (medicine, nursing, allied health), social care, or education professionals with ≥6 months' experience caring for children with LLCs.

    Exclusion

    Professionals with <6 months' experience.

    4.4 Workshop Participants

    Drawn from interview participants and wider networks.

    Must be able to provide informed consent.

    Children are not included in workshops.

    Sample Size Estimates

    Interviews: 10-20 children, ≥30 parents/carers, ≥30 professionals.

    Workshops: ~90 participants across three initial workshops and one consensus session.

  5. Study Procedures 5.1 Interviews

    Conducted face-to-face or via secure video (Microsoft Teams).

    Duration: children (30-60 min), parents (60-90 min), professionals (~60 min).

    Interviews will be audio-recorded, transcribed verbatim, pseudonymised.

    Children's interviews will include rapport-building, discussion of daily life, care needs, support experiences, and hopes for improvement.

    Parents will be asked about daily care, experiences with services, barriers, and views on complexity.

    Professionals will discuss definitions of complexity, service challenges, and approaches to integration.

    Participants will receive £20 vouchers and reimbursement for travel/childcare.

    5.2 Workshops

    Conducted remotely via Microsoft Teams to maximise accessibility.

    Three initial workshops will generate broad definitions and frameworks.

    A final workshop will synthesise findings using Nominal Group Technique.

    Outputs: consensus definition of complexity and a preliminary logic model.

  6. Data Management and Analysis Plan

    All identifiable data (e.g., consent forms, audio/video files) will be stored separately from transcripts.

    Data will be held on secure, password-protected King's College London SharePoint servers.

    Audio files will be transcribed by a GDPR-compliant service; audio destroyed after transcription.

    Video recordings of Talking Mats™ sessions will be analysed then deleted.

    Interview data will be analysed using Framework Analysis, ensuring transparency, coding consistency, and traceability.

    Workshop data will be analysed using Nominal Group Technique and the CDC guide for developing logic models.

    Emergent findings will be triangulated across children, parents, and professionals.

  7. Statistical Considerations

    This is a qualitative study; no hypothesis testing or quantitative statistical modelling is planned. Sample sizes are based on principles of pragmatic saturation, ensuring adequate diversity and depth of data.

    Interviews: expected saturation with ~60-80 participants.

    Workshops: sufficient numbers to capture balance between parents and professionals, with consensus tested through structured group methods.

  8. Ethics, Safety, and Risk Management

    Ethical Review: The study requires NHS REC and HRA approval.

    Informed Consent/Assent

    Parents provide written consent for themselves and for children under 16.

    Children aged 5-15 provide assent; those aged 16-17 provide consent where capacity is confirmed.

    Bereaved parents must be at least 3 months post-bereavement.

    Managing Distress

    Researchers trained in qualitative methods for sensitive topics.

    Distress protocol includes pausing/stopping interviews, signposting to support, and notifying care teams if needed.

    No disclosure of prognosis or new medical information will occur during interviews.

    Adverse Events

    Although AEs and SAEs are unlikely in qualitative research, any unexpected events (e.g., acute distress) will be recorded and reported according to NIHR and sponsor policies.

    Safeguarding

    The study complies with NIHR and KCL safeguarding guidelines.

    Children may have a parent or trusted adult present during interviews.

  9. Oversight, Roles, and Responsibilities

    Sponsor: King's College London - responsible for study initiation, management, and monitoring.

    Funder: NIHR Programme Development Grant (NIHR207608).

    Chief Investigator: Prof. Richard Harding (Cicely Saunders Institute).

    Co-Investigators: Multidisciplinary team spanning paediatric medicine, social care, ethics, education, and patient/public representation.

    Steering Committee: Includes patient and public involvement (PPI) members and professionals, meeting monthly to guide recruitment, methodology, and interpretation.

    Auditing/Monitoring: Sponsor may audit per UK Policy Framework for Health and Social Care.

  10. Dissemination and Impact

Findings will inform the development of a cross-sector conceptual model of complexity, which will underpin a subsequent NIHR Programme Grant proposal. Dissemination plans include:

Peer-reviewed publications in palliative care, paediatrics, education, and social policy journals.

Presentations at international conferences.

A public launch of the consensus definition, involving parents and carers.

Sharing findings with NHS England, local authorities, and professional associations.

Lay summaries and online dissemination co-developed with PPI representatives.

Ultimately, the study aims to provide a nationally applicable, child-centred framework for understanding complexity in LLCs, enabling more equitable service design, evaluation, and resource allocation.

Study Type

Observational

Enrollment (Estimated)

170

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Contact

Study Contact Backup

Study Locations

      • Birmingham, United Kingdom, B46NH
        • Birmingham Children's Hospital
        • Contact:
      • Chailey, United Kingdom, BN84JN
        • Chailey Clinical Services, Sussex Community NHS Foundation Trust
        • Contact:
      • Hampton, United Kingdom, TW12 3RA
      • London, United Kingdom, SE1 9RT
        • Guy's and St Thomas' NHS Foundation Trust
        • Contact:
      • London, United Kingdom, SW36JJ

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Child
  • Adult
  • Older Adult

Accepts Healthy Volunteers

No

Sampling Method

Non-Probability Sample

Study Population

The study population comprises: (1) children and young people aged 5-17 years with a life-limiting condition; (2) parents or carers of children aged 0-17, including bereaved parents (≥3 months post-bereavement); and (3) professionals from health, education, and social care with ≥6 months' experience supporting this population. Participants will be recruited from five NHS and hospice sites across England, selected for variation in geography, population served, and service model. Purposive sampling will be used to ensure diversity in age, diagnosis, ethnicity, socioeconomic status, and care setting. Professionals will be drawn from a range of disciplines across sectors using our professional networks.

Description

Stage 1 - Interviews

Inclusion Criteria:

  • Children (5-17 years) with any life-limiting condition defined using the UK Together for Short Lives widely adopted 4 categories of life-limiting/life-threatening conditions among children.
  • Parents/carers of children (0-17 years old) with a life-limiting conditions.
  • Bereaved parents of a child who had a life-limiting condition (at least 3 months since bereavement).
  • Healthcare professionals (medicine, nursing, allied health professionals), social care providers, education teaching and therapy staff with > 6 months experience of caring for children with life-limiting conditions.

Exclusion Criteria:

  • Children unable to communicate via an interview, using 'draw and talk' or play methods, Talking MatsTM, or via their parents.
  • Children that speak languages not supported by NHS translation services.
  • Any child or young person for whom the PI believes participation in the study may induce undue psychological distress.
  • Parents/carers are unable to provide consent/assent to participate in interviews.
  • Parents/carers that speak languages not supported by NHS translation services.
  • Parents who are recently bereaved (<3 months).
  • Any parent/carer for whom the PI believes participation in the study may induce undue psychological distress (e.g. parents of children who may be receiving end-of-life care).
  • Professionals with <6 months experience of caring for children with life-limiting conditions.

Stage 2 - Workshops

Inclusion criteria:

  • Parents or carers of children with a life-limiting condition (0-17 years old).
  • Bereaved parents of a child who had a life-limiting condition (at least 3 months since bereavement).
  • Researchers working with or in the field of complexity in children with life-limiting conditions.
  • Professionals across child health, social care, and education with experience of working with children with life-limiting conditions for >6 months.

Exclusion criteria:

  • Professionals across child health, social care, and education with <6 months of experience working with children with life-limiting conditions.
  • Parents, carers, or professionals that are unable to provide consent or assent.
  • Children with life-limiting/life-threatening conditions will not be included in the workshops
  • Parents who are recently bereaved (<3 months) of a child who had a life-limiting condition.

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

Cohorts and Interventions

Group / Cohort
Intervention / Treatment
Interview and Workshop Participants

Interview and workshop participants will be formed from the following inclusion criteria:

Children and Young People (CYP):

  • Aged 5-17 years
  • Diagnosed with a life-limiting condition (as defined by Together for Short Lives)

Parents/Carers:

  • Parent/carer of a child aged 0-17 years with a life-limiting condition
  • Bereaved parent, where bereavement occurred ≥3 months ago

Professionals (Health, Social Care, Education):

  • Working with CYP with life-limiting conditions for at least 6 months
  • Includes medical, nursing, allied health, social care, and educational professionals

Workshop Participants:

  • Any of the above stakeholder types
  • Must be able to provide informed consent or assent
Children and young people with life-limiting conditions, their parents/carers, and professionals across healthcare, education, and social care sectors.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Study Objective
Time Frame: Total Duration of study - August 2025 to July 2026.
Use findings from stakeholder interviews and workshops to develop a cross-sector evidence-based conceptual model of complexity to inform delivery and assessment of high quality and integrated care.
Total Duration of study - August 2025 to July 2026.
Interviews - Research Question
Time Frame: Total study duration - August 2025 to July 2026
What does 'complexity' mean to stakeholders in relation to children with life-limiting conditions, with respect to their health, social care, and educational needs and how they are understood, planned, and delivered?
Total study duration - August 2025 to July 2026
Workshops Research Questions
Time Frame: Total study duration - August 2025 to July 2026
  1. How is 'complexity' defined and operationalised across health, social care, and education for children and young people with life-limiting conditions?
  2. What components and processes are important for the delivery of integrated complex care?
  3. What outputs and indicators signal 'complexity' and appropriate care delivery?
  4. Which processes and outcomes are meaningful to evaluate?
Total study duration - August 2025 to July 2026

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Sponsor

Collaborators

Investigators

  • Principal Investigator: Fliss Murtagh, Hull York Medical School
  • Principal Investigator: Mary Baginsky, King's College London
  • Principal Investigator: Diane Sellers, Chailey Clinical Services, Sussex Community NHS Foundation Trust
  • Principal Investigator: Lucy Coombes, Royal Marsden NHS Foundation Trust
  • Principal Investigator: Mary Salama, Birmingham Children's Hospital
  • Principal Investigator: Bobbie Farsides, Brighton and Sussex Medical School
  • Principal Investigator: Gabriella L Walker, Patient and Public Representative
  • Principal Investigator: Pru Holder, King's College London
  • Principal Investigator: Abinaya Chandrasekar, King's College London

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

General Publications

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Estimated)

December 1, 2025

Primary Completion (Estimated)

July 31, 2026

Study Completion (Estimated)

July 31, 2026

Study Registration Dates

First Submitted

July 28, 2025

First Submitted That Met QC Criteria

July 28, 2025

First Posted (Actual)

August 3, 2025

Study Record Updates

Last Update Posted (Estimated)

November 14, 2025

Last Update Submitted That Met QC Criteria

November 13, 2025

Last Verified

July 1, 2025

More Information

Terms related to this study

Other Study ID Numbers

  • IRAS 356844
  • NIHR207608 (Other Identifier: National Institute for Health and Care Research)

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

IPD Plan Description

This is a qualitative study involving in-depth interviews and stakeholder workshops with children, parents (including bereaved parents), and professionals. Due to the nature of the data collected-highly personal, context-specific, and potentially identifiable-even after de-identification, individual participant data (IPD) will not be shared publicly. This decision is guided by ethical considerations, the sensitivity of participant narratives, and the need to preserve confidentiality in accordance with informed consent agreements and data governance policies. Summarised findings will be shared through academic publications, public reports, and stakeholder events.

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Pediatrics

Search Similar Trials